Risks associated with use of TNF inhibitors in children with rheumatic diseases

Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors

(2018) Timothy Beukelman et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations

(2018) Achille Marino et al.   CLINICAL RHEUMATOLOGY

Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective study

(2018) Alexandra Okihiro et al.   Pediatric Rheumatology

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

(2017) Magali Lemaitre et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study

(2017) Florence A. Aeschlimann et al.   JOURNAL OF RHEUMATOLOGY

Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents

(2017) Joshua B. Eickstaedt et al.   PEDIATRIC DERMATOLOGY

Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center

(2017) Achille Marino et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study

(2017) P. C. E. Hissink Muller et al.   Pediatric Rheumatology

Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis

(2017) Wan-Ju Lee et al.   RHEUMATOLOGY

Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment

(2017) Noortje Groot et al.   VACCINE

Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry

(2017) Ingrid Becker et al.   ARTHRITIS CARE & RESEARCH

Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting

(2017) Serena Pastore et al.   PEDIATRIC DRUGS

Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

(2016) Louise K Mercer et al.   ANNALS OF THE RHEUMATIC DISEASES

Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease

(2016) Benjamin Alexandre et al.   Journal of Crohns & Colitis

Palisaded Neutrophilic Granulomatous Dermatitis in a Child with Juvenile Idiopathic Arthritis on Etanercept

(2016) Tuyet A. Nguyen et al.   PEDIATRIC DERMATOLOGY

Case Report of Lichen Planopilaris Occurring in a Pediatric Patient Receiving a Tumor Necrosis Factor α Inhibitor and a Review of the Literature

(2016) Prativa S.A. Jayasekera et al.   PEDIATRIC DERMATOLOGY

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept

(2016) Sara Verazza et al.   Pediatric Rheumatology

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

(2015) Jens Klotsche et al.   ANNALS OF THE RHEUMATIC DISEASES

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium

(2015) B. Rup et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Safety of biologic therapies for the treatment of juvenile idiopathic arthritis

(2015) Gerd Horneff   Expert Opinion On Drug Safety

Tuberculosis in pediatric patients treated with anti-TNFα drugs: a cohort study

(2015) Joan Calzada-Hernández et al.   Pediatric Rheumatology

Incidence of herpes zoster infections in juvenile idiopathic arthritis patients

(2015) S. Nimmrich et al.   RHEUMATOLOGY INTERNATIONAL

Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response

(2015) A Skrabl-Baumgartner et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy

(2015) N. Toplak et al.   VACCINE

Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study

(2015) Rebecca Davies et al.   Arthritis & Rheumatology

Clinical Utility of Random Anti-Tumor Necrosis Factor Drug-Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis

(2015) Meghna Jani et al.   Arthritis & Rheumatology

2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among C

(2015) Sarah Ringold et al.   ARTHRITIS AND RHEUMATISM

Risk of malignancy associated with biologic agents in pediatric rheumatic disease

(2014) Melissa L. Mannion et al.   CURRENT OPINION IN RHEUMATOLOGY

Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis

(2014) Susanna Esposito et al.   Expert Review of Vaccines

Mechanisms of Tumor Necrosis Factor α Antagonist-Induced Lupus in a Murine Model

(2014) Yuan Xu et al.   Arthritis & Rheumatology

Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study

(2013) Susanne P Stoof et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study

(2013) Marloes W Heijstek et al.   ANNALS OF THE RHEUMATIC DISEASES

Brief Report: Incidence of Selected Opportunistic Infections Among Children With Juvenile Idiopathic Arthritis

(2013) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases

(2013) C. Sengler et al.   CLINICAL RHEUMATOLOGY

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

(2013) Cornelia Tillack et al.   GUT

Effects of the Live Attenuated Measles-Mumps-Rubella Booster Vaccination on Disease Activity in Patients With Juvenile Idiopathic Arthritis

(2013) Marloes W. Heijstek et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prospective surveillance study of acute respiratory infections, influenza-like illness and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients

(2013) Luciana M Carvalho et al.   Pediatric Rheumatology

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

(2012) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Rates of malignancy associated with juvenile idiopathic arthritis and its treatment

(2012) Timothy Beukelman et al.   ARTHRITIS AND RHEUMATISM

Relapse of Systemic Juvenile Idiopathic Arthritis after Influenza Vaccination in a Patient Receiving Tocilizumab

(2012) Masaki Shimizu et al.   Clinical and Vaccine Immunology

Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan

(2012) Tomoyuki Imagawa et al.   CLINICAL RHEUMATOLOGY

Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy

(2012) Maria A. Lopez-Olivo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Infliximab-Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL-23 Receptor Polymorphisms

(2012) Mary E. Sherlock et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic

(2012) David A. Wetter et al.   MAYO CLINIC PROCEEDINGS

Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis

(2012) NE Aikawa et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents

(2012) Beth L. Nordstrom et al.   ARTHRITIS CARE & RESEARCH

Hepatitis B Immunity and Response to Booster Vaccination in Children With Inflammatory Bowel Disease Treated With Infliximab

(2011) Jonathan Moses et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

(2011) X. Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

(2011) M. W. Heijstek et al.   ANNALS OF THE RHEUMATIC DISEASES

Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial

(2011) P. Tynjala et al.   ANNALS OF THE RHEUMATIC DISEASES

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis

(2011) Carol A. Wallace et al.   ARTHRITIS AND RHEUMATISM

Skin Manifestations Induced by TNF-Alpha Inhibitors in Juvenile Idiopathic Arthritis

(2011) Irene Pontikaki et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-α inhibitors

(2011) Andreas Woerner et al.   Human vaccines & immunotherapeutics

Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up

(2011) Geertje M. Bartelds   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells

(2011) A. A. Kruglov et al.   JOURNAL OF IMMUNOLOGY

Five Cases of Anti-Tumor Necrosis Factor Alpha-Induced Psoriasis Presenting with Severe Scalp Involvement in Children

(2011) Marissa J. Perman et al.   PEDIATRIC DERMATOLOGY

Hepatitis B virus reactivation in a Juvenile Rheumatoid arthritis patient under treatment and its successful management: a complicated case

(2011) Oguz Durmus et al.   RHEUMATOLOGY INTERNATIONAL

Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis

(2011) Laura Dell’Era et al.   VACCINE

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

(2010) N. Ruperto et al.   ANNALS OF THE RHEUMATIC DISEASES

Juvenile idiopathic arthritis and risk of cancer: A nationwide cohort study

(2010) J. F. Simard et al.   ARTHRITIS AND RHEUMATISM

Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration

(2010) Peter Diak et al.   ARTHRITIS AND RHEUMATISM

Anti-TNF-α Treatment: A Possible Promoter in Endogenous Uveitis? Observational Report on Six Patients: Occurrence of Uveitis Following Etanercept Treatment

(2010) Vinodh Kakkassery et al.   CURRENT EYE RESEARCH

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

(2010) I. Solovic et al.   EUROPEAN RESPIRATORY JOURNAL

Neurological adverse events associated with anti-tumor necrosis factor alpha treatment

(2010) Antonio G. Tristano   JOURNAL OF NEUROLOGY

The safety and side effects of monoclonal antibodies

(2010) Trevor T. Hansel et al.   NATURE REVIEWS DRUG DISCOVERY

Occurrence of Pustular Psoriasis after Treatment of Crohn Disease with Infliximab

(2010) CRYSTAL POURCIAU et al.   PEDIATRIC DERMATOLOGY

Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab

(2010) Miha Kosmač et al.   PEDIATRIC RESEARCH

The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis

(2010) Evangelia Farmaki et al.   VACCINE

Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort

(2010) Kiem Oen et al.   ARTHRITIS CARE & RESEARCH

Immune Response to Influenza Vaccine in Children With Inflammatory Bowel Disease

(2009) Ying Lu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Psoriasis secundaria al tratamiento con infliximab y adalimumab en la enfermedad de Crohn

(2009) A. Ávila Álvarez et al.   ANALES DE PEDIATRIA

Endemic Fungal Infections in Patients Receiving Tumour Necrosis Factor-α Inhibitor Therapy

(2009) Jeannina A. Smith et al.   DRUGS

Anti-TNF-induced lupus

(2009) E. L. Williams et al.   RHEUMATOLOGY

A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period

(2009) Seigo Korematsu et al.   VACCINE

Genotoxicity of anti–tumor necrosis factor therapy in patients with juvenile idiopathic arthritis

(2009) Erkan Demirkaya et al.   ARTHRITIS CARE & RESEARCH

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor   therapy: results from the British Society for Rheumatology Biologics Register

(2008) M J Harrison et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) Daniel J. Lovell et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Incidence Among Children and Adolescents in the United States, 2001-2003

(2008) J. Li et al.   PEDIATRICS

Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept

(2008) S. Borte et al.   RHEUMATOLOGY